resveratrol has been researched along with Atrial Remodeling in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Liu, Z; Sheng, L; Yuan, Y; Zhang, S; Zhang, Y; Zhao, X | 1 |
Doser, TA; Ge, J; Hu, N; Mi, SL; Ren, J; Sun, A; Zhang, Y | 1 |
Arnal, JF; Grimaud, L; Guihot, AL; Henrion, D; Loufrani, L; Menet, MC; Nivet-Antoine, V; Petit, M; Procaccio, V; Toutain, B; Vessieres, E | 1 |
3 other study(ies) available for resveratrol and Atrial Remodeling
Article | Year |
---|---|
Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Anti-Arrhythmia Agents; Arthritis, Experimental; Atrial Fibrillation; Atrial Remodeling; Female; Fibrosis; Glycogen; Heart Atria; Interleukin-6; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Kinases; Rats, Wistar; Resveratrol; Tumor Necrosis Factor-alpha | 2018 |
Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.
Topics: Aging; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; AMP-Activated Protein Kinases; Animals; Apoptosis; Atrial Remodeling; Benzamides; Benzodioxoles; Calcium; Cardiomegaly; Fibrosis; Gene Expression Regulation; Heterocyclic Compounds, 4 or More Rings; Ion Channels; Mice; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Proteins; Myocardial Contraction; Myocardium; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Superoxides; Transcription Factors; Uncoupling Protein 2 | 2014 |
Resveratrol Improved Flow-Mediated Outward Arterial Remodeling in Ovariectomized Rats with Hypertrophic Effect at High Dose.
Topics: Animals; Atrial Remodeling; Endothelium, Vascular; Female; Membrane Glycoproteins; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Contraction; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide Synthase Type III; Ovariectomy; Oxidative Stress; Phenylephrine; Phosphorylation; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxides; Vasodilator Agents | 2016 |